radiotherapy devices market growth
Medical Equipment

Radiotherapy Devices Global Market Outlook 2024-2033: Size And Growth Rate Analysis

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

the radiotherapy devices market has witnessed a remarkable surge, evolving from a $5.71 billion industry in 2023 to a projected $6.29 billion in 2024, representing a robust compound annual growth rate (CAGR) of 10.3%. This trajectory is attributed to several key factors, including the growing incidence of cancer, a shift towards patient-centric care, an aging population, increased awareness of radiotherapy devices, and the rise of teletherapy and remote monitoring.

Current Landscape and Growth Projections

  1. Historic Period Drivers:
  • Growing incidence of cancer
  • Emphasis on patient-centric care
  • Aging population
  • Increasing awareness of radiotherapy devices
  • Surge in teletherapy and remote monitoring
  1. Forecast Period Drivers:
  • Proton therapy expansion
  • Immunotherapy combination
  • Remote monitoring and teletherapy
  • Growing demand for precise and targeted radiation treatments
  • Adoption of minimally invasive radiotherapy techniques
  1. Major Trends in Forecast Period:
  • Proton therapy advancements
  • Hypofractionated radiotherapy
  • Adaptive radiotherapy
  • Patient experience enhancement
  • Artificial intelligence (AI) integration

View More On The Radiotherapy Devices Market Report 2024 –

Clinical Trials Propelling Market Growth
The escalating number of clinical trials stands as a key driver for the ongoing and future growth of the radiotherapy devices market. Clinical trials play a pivotal role in evaluating the safety and efficacy of medical treatments and devices. In May 2023, Xtalks reported a staggering 452,604 registered clinical studies, with 64,838 actively seeking participants. These trials serve to ensure that radiotherapy devices deliver radiation accurately and as intended. The surge in clinical trials is indicative of the industry’s commitment to innovation and continuous improvement.

Major Companies in the Radiotherapy Devices Market:

  • Varian Medical Systems Inc.
  • Elekta AB
  • Accuray Incorporated
  • Becton Dickinson and Company
  • IBA Ion Beam Applications SA
  • Koninklijke Philips N.V.
  • Panacea Medical Technologies Pvt. Ltd.
  • P-Cure Ltd.
  • Provision Healthcare LLC
  • Sumitomo Heavy Industries Ltd.
  • ViewRay Inc.
  • Miranda Medical
  • Nordion Inc.
  • NTP Radioisotopes SOC Ltd.
  • Curium
  • Hitachi Ltd.
  • Brainlab AG
  • Best Theratronics Ltd.
  • ProTom International Inc.

Innovative Technologies Shaping the Market
Major players in the industry are driving innovation with the introduction of transformative technologies. A notable example is the Versa HD, a linear accelerator system for radiation therapy. Launched by Mitchell Cancer Institute in May 2023, this technology facilitates Volumetric Modulated Arc Therapy (VMAT) for expedited treatments and an enhanced patient experience. High-Definition Dynamic Radiosurgery (HDRS) further showcases the versatility of Versa HD, converting the linac into a specialized Stereotactic Radiosurgery (SRS) solution.

Strategic Acquisitions to Expand Portfolio

  1. Bebig Medical’s Acquisition:
  • In July 2022, BEBIG Medical GmbH acquired Wolf-Medizintechnik GmbH.
  • The acquisition expanded BEBIG Medical’s X-ray therapy devices for joint ailments and superficial skin cancers.
  • A strategic move to enhance the market position and product offerings in brachytherapy equipment.

Segmentation of the Radiotherapy Devices Market

  1. Product Type:
    • External Beam Radiation Therapy Devices
    • Linear Accelerator Devices
    • Proton Therapy Devices
  2. Application:
    • Skin Cancer
    • Breast Cancer
    • Prostate Cancer
    • Cervical Cancer
    • Lung Cancer
    • Other Applications
  3. End Users:
    • Hospitals
    • Ambulatory Surgical Centers
    • Oncological Treatment Centers

Geographical Dominance
In 2023, North America emerged as the largest region in the radiotherapy devices market, underscoring the region’s prominence in healthcare infrastructure and technological advancements.

In conclusion, the dynamic growth of the radiotherapy devices market is fueled by a combination of technological innovation, strategic acquisitions, and a commitment to advancing patient care. As the industry continues to evolve, embracing trends such as proton therapy advancements and artificial intelligence integration, it holds the promise of delivering more effective and personalized radiation treatments, thereby contributing to the fight against cancer on a global scale.

Request A Sample Of The Global Radiotherapy Devices Market Report 2024: